Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 8
2011 7
2012 15
2013 12
2014 14
2015 9
2016 2
2017 1
2018 3
2019 2
2020 4
2021 5
2022 12
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
JMJD family proteins in cancer and inflammation.
Manni W, Jianxin X, Weiqi H, Siyuan C, Huashan S. Manni W, et al. Among authors: huashan s. Signal Transduct Target Ther. 2022 Sep 1;7(1):304. doi: 10.1038/s41392-022-01145-1. Signal Transduct Target Ther. 2022. PMID: 36050314 Free PMC article. Review.
Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R, Manochakian R, James L, Azzouqa AG, Shi H, Zhang Y, Zhao Y, Zhou K, Lou Y. Chen R, et al. Among authors: shi h. J Hematol Oncol. 2020 May 24;13(1):58. doi: 10.1186/s13045-020-00881-7. J Hematol Oncol. 2020. PMID: 32448366 Free PMC article. Review.
Editorial: The Clinical Application of Neoantigens.
Zhou JG, Ding Z, Shi H, Cheng M. Zhou JG, et al. Among authors: shi h. Front Immunol. 2022 Mar 3;13:842633. doi: 10.3389/fimmu.2022.842633. eCollection 2022. Front Immunol. 2022. PMID: 35309343 Free PMC article. No abstract available.
Small molecule inhibitors targeting the cancers.
Liu GH, Chen T, Zhang X, Ma XL, Shi HS. Liu GH, et al. MedComm (2020). 2022 Oct 13;3(4):e181. doi: 10.1002/mco2.181. eCollection 2022 Dec. MedComm (2020). 2022. PMID: 36254250 Free PMC article. Review.
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.
Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W. Li D, et al. Among authors: shi h. Sci Adv. 2023 Dec;9(48):eadg9721. doi: 10.1126/sciadv.adg9721. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039357 Free PMC article.
104 results